Home
AMRX
AMRX News

Latest Amneal Pharmaceuticals Inc. (AMRX) News on April 2, 2025

Amneal Launches BORUZU™, First Ready-to-Use Bortezomib Injection for Multiple Myeloma and Mantle Cell Lymphoma

Business Wire

21 hours ago

Amneal Launches BORUZU™, First Ready-to-Use Bortezomib Injection for Multiple Myeloma and Mantle Cell Lymphoma

Amneal to Participate at Upcoming Investor Conference

Business Wire

23 days ago

Amneal to Participate at Upcoming Investor Conference

Amneal’s BLA Submissions for Two Denosumab Biosimilars Accepted for Review by U.S. FDA

Business Wire

a month ago

Amneal’s BLA Submissions for Two Denosumab Biosimilars Accepted for Review by U.S. FDA

Amneal Pharmaceuticals Full Year 2024 Earnings: EPS Misses Expectations

Simply Wall St.

a month ago

Amneal Pharmaceuticals Full Year 2024 Earnings: EPS Misses Expectations

Amneal Reports Fourth Quarter and Full Year 2024 Financial Results

Business Wire

a month ago

Amneal Reports Fourth Quarter and Full Year 2024 Financial Results

Amneal Pharmaceuticals Inc (AMRX) Q4 2024: Everything You Need To Know Ahead Of Earnings

GuruFocus.com

a month ago

Amneal Pharmaceuticals Inc (AMRX) Q4 2024: Everything You Need To Know Ahead Of Earnings

Amneal Launches Mesalamine and Receives U.S. FDA Approval for Lenalidomide

Business Wire

a month ago

Amneal Launches Mesalamine and Receives U.S. FDA Approval for Lenalidomide

Although Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) insiders have sold lately, they have the highest ownership with 51% stake

Simply Wall St.

2 months ago

Although Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) insiders have sold lately, they have the highest ownership with 51% stake

7MM PD market to grow by $4.5bn between 2023 and 2033

Clinical Trials Arena

2 months ago

7MM PD market to grow by $4.5bn between 2023 and 2033

Amneal to Report Fourth Quarter and Full Year 2024 Results on February 28, 2025

Business Wire

2 months ago

Amneal to Report Fourth Quarter and Full Year 2024 Results on February 28, 2025

Kashiv Biosciences’ Phase I trial of KSHB002 injection meets primary endpoints

Clinical Trials Arena

2 months ago

Kashiv Biosciences’ Phase I trial of KSHB002 injection meets primary endpoints

Amneal Receives U.S. FDA Approval for Memantine/Donepezil Extended-Release Capsules and Everolimus Tablets for Oral Suspension, and Tentative U.S. FDA Approval for Rifaximin

Business Wire

2 months ago

Amneal Receives U.S. FDA Approval for Memantine/Donepezil Extended-Release Capsules and Everolimus Tablets for Oral Suspension, and Tentative U.S. FDA Approval for Rifaximin

Amneal to Participate at Upcoming Investor Conferences

Business Wire

4 months ago

Amneal to Participate at Upcoming Investor Conferences

Amneal Resubmits DHE Autoinjector New Drug Application and Receives U.S. FDA Approval of Exenatide, its First Generic Injectable GLP-1 Agonist

Business Wire

4 months ago

Amneal Resubmits DHE Autoinjector New Drug Application and Receives U.S. FDA Approval of Exenatide, its First Generic Injectable GLP-1 Agonist

Amneal Pharmaceuticals Inc (AMRX) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ...

GuruFocus.com

5 months ago

Amneal Pharmaceuticals Inc (AMRX) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ...

Amneal Reports Third Quarter 2024 Financial Results

Business Wire

5 months ago

Amneal Reports Third Quarter 2024 Financial Results

Earnings To Watch: Amneal Pharmaceuticals Inc (AMRX) Reports Q3 2024 Result

GuruFocus.com

5 months ago

Earnings To Watch: Amneal Pharmaceuticals Inc (AMRX) Reports Q3 2024 Result

Amneal Pharmaceuticals (NASDAQ:AMRX) grows 3.0% this week, taking five-year gains to 211%

Simply Wall St.

5 months ago

Amneal Pharmaceuticals (NASDAQ:AMRX) grows 3.0% this week, taking five-year gains to 211%

Amneal Receives U.S. FDA Approval of New Drug Application for Pyridostigmine Bromide Extended-Release Tablets

Business Wire

5 months ago

Amneal Receives U.S. FDA Approval of New Drug Application for Pyridostigmine Bromide Extended-Release Tablets

Amneal Pharmaceuticals Inc (AMRX) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and ...

GuruFocus.com

6 months ago

Amneal Pharmaceuticals Inc (AMRX) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and ...

Amneal to Report Third Quarter 2024 Results on November 8, 2024

Business Wire

6 months ago

Amneal to Report Third Quarter 2024 Results on November 8, 2024

Amneal and Metsera Announce Strategic Collaboration to Develop and Supply Portfolio of Next-Generation Medicines for Obesity and Metabolic Diseases

Business Wire

6 months ago

Amneal and Metsera Announce Strategic Collaboration to Develop and Supply Portfolio of Next-Generation Medicines for Obesity and Metabolic Diseases

Amneal Launches CREXONT® (Carbidopa and Levodopa) Extended-Release Capsules for Treatment of Parkinson’s Disease

Business Wire

6 months ago

Amneal Launches CREXONT® (Carbidopa and Levodopa) Extended-Release Capsules for Treatment of Parkinson’s Disease

Amneal and Shilpa Announce U.S. FDA Approval of BORUZU™, the First Ready-to-Use Version of Bortezomib for subcutaneous administration

Business Wire

7 months ago

Amneal and Shilpa Announce U.S. FDA Approval of BORUZU™, the First Ready-to-Use Version of Bortezomib for subcutaneous administration

Amneal Receives U.S. FDA Approval for Propofol Injectable Emulsion Single Dose Vials

Business Wire

7 months ago

Amneal Receives U.S. FDA Approval for Propofol Injectable Emulsion Single Dose Vials

Insider Sale at Amneal Pharmaceuticals Inc (AMRX): Executive Vice President Nikita Shah Sells ...

GuruFocus.com

8 months ago

Insider Sale at Amneal Pharmaceuticals Inc (AMRX): Executive Vice President Nikita Shah Sells ...

Amneal Pharmaceuticals Second Quarter 2024 Earnings: EPS: US$0.019 (vs US$0.078 in 2Q 2023)

Simply Wall St.

8 months ago

Amneal Pharmaceuticals Second Quarter 2024 Earnings: EPS: US$0.019 (vs US$0.078 in 2Q 2023)

Amneal Reports Second Quarter 2024 Financial Results

Business Wire

8 months ago

Amneal Reports Second Quarter 2024 Financial Results

Amneal Receives U.S. FDA Approval for IPX203 for Treatment of Parkinson’s Disease to Be Launched as CREXONT® (Carbidopa and Levodopa) Extended-Release Capsules

Business Wire

8 months ago

Amneal Receives U.S. FDA Approval for IPX203 for Treatment of Parkinson’s Disease to Be Launched as CREXONT® (Carbidopa and Levodopa) Extended-Release Capsules

Amneal Receives U.S. FDA Approval for Potassium Phosphates Injection IV Bags

Business Wire

8 months ago

Amneal Receives U.S. FDA Approval for Potassium Phosphates Injection IV Bags

In spite of recent selling, insiders still control 53% of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)

Simply Wall St.

8 months ago

In spite of recent selling, insiders still control 53% of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX)

Amneal to Report Second Quarter 2024 Results on August 9, 2024

Business Wire

9 months ago

Amneal to Report Second Quarter 2024 Results on August 9, 2024

Amneal Launches FOCINVEZ™, the First Ready-to-Use Version of Fosaprepitant

Business Wire

9 months ago

Amneal Launches FOCINVEZ™, the First Ready-to-Use Version of Fosaprepitant

Amneal Expands Biosimilars Portfolio to Eight Products with Addition of Omalizumab Biosimilar

Business Wire

9 months ago

Amneal Expands Biosimilars Portfolio to Eight Products with Addition of Omalizumab Biosimilar

Business Wire

9 months ago

Kashiv BioSciences Enters into Exclusive Licensing Agreement with Amneal for Commercialization of a Proposed Biosimilar to XOLAIR® (Omalizumab)

Amneal Releases 2023 Environmental, Social and Governance Report

Business Wire

9 months ago

Amneal Releases 2023 Environmental, Social and Governance Report

A Data-Driven Analysis of Netflix's Streaming Dominance and Future Outlook

GuruFocus.com

10 months ago

A Data-Driven Analysis of Netflix's Streaming Dominance and Future Outlook

Energy Global

10 months ago

ANDRITZ to equip new Silvan hydropower plant in Türkiye

Supreme Court Justice Alito talks polarization, his wife talks revenge in secret recordings

USA TODAY

10 months ago

Supreme Court Justice Alito talks polarization, his wife talks revenge in secret recordings

Pacer ETFs Rings in its 9th Anniversary as Firm nears $50 Billion in Assets Under Management

Business Wire

10 months ago

Pacer ETFs Rings in its 9th Anniversary as Firm nears $50 Billion in Assets Under Management

Indra Energy Drives Sustainability Focus through the Penguins Pledge with the Pittsburgh Penguins

Business Wire

10 months ago

Indra Energy Drives Sustainability Focus through the Penguins Pledge with the Pittsburgh Penguins

SEALSQ to Launch Two New Quantum Resistant Chips

GlobeNewswire

10 months ago

SEALSQ to Launch Two New Quantum Resistant Chips

Shrinking Fed rate cut expectations to keep US Treasury yields elevated: Reuters poll

Reuters

10 months ago

Shrinking Fed rate cut expectations to keep US Treasury yields elevated: Reuters poll

Global Upstream Bioprocessing Market Analysis Report 2024-2030: A $59.24 Billion Market by 2030, Registering a CAGR of 14.3% from 2024 to 2030

GlobeNewswire

10 months ago

Global Upstream Bioprocessing Market Analysis Report 2024-2030: A $59.24 Billion Market by 2030, Registering a CAGR of 14.3% from 2024 to 2030

Amneal Expands Broad Injectables Portfolio to Over 40 Products with the Addition of Six New Therapies

Business Wire

10 months ago

Amneal Expands Broad Injectables Portfolio to Over 40 Products with the Addition of Six New Therapies

Amneal Begins Supplying Over-the-Counter Naloxone Hydrochloride Nasal Spray to U.S. Retail Pharmacies and the State of California

Business Wire

10 months ago

Amneal Begins Supplying Over-the-Counter Naloxone Hydrochloride Nasal Spray to U.S. Retail Pharmacies and the State of California

Amneal to Participate at Upcoming Investor Conference

Business Wire

10 months ago

Amneal to Participate at Upcoming Investor Conference

Insider Sale: Director Deborah Autor Sells 38,000 Shares of Amneal Pharmaceuticals Inc (AMRX)

GuruFocus.com

10 months ago

Insider Sale: Director Deborah Autor Sells 38,000 Shares of Amneal Pharmaceuticals Inc (AMRX)

Amneal Pharmaceuticals First Quarter 2024 Earnings: US$0.30 loss per share (vs US$0.046 loss in 1Q 2023)

Simply Wall St.

a year ago

Amneal Pharmaceuticals First Quarter 2024 Earnings: US$0.30 loss per share (vs US$0.046 loss in 1Q 2023)

GuruFocus.com

a year ago

Amneal Pharmaceuticals Inc (AMRX) Q1 2024 Earnings Call Transcript Highlights: Robust Growth ...

Amneal Reports First Quarter 2024 Financial Results

Business Wire

a year ago

Amneal Reports First Quarter 2024 Financial Results

Amneal Announces U.S. FDA Approval of Over-the-Counter Naloxone Hydrochloride Nasal Spray for Emergency Treatment of an Opioid Overdose

Business Wire

a year ago

Amneal Announces U.S. FDA Approval of Over-the-Counter Naloxone Hydrochloride Nasal Spray for Emergency Treatment of an Opioid Overdose

Amneal Launches PEMRYDI RTU®, the First Ready-to-Use Version of Important Oncology Injectable Medicine

Business Wire

a year ago

Amneal Launches PEMRYDI RTU®, the First Ready-to-Use Version of Important Oncology Injectable Medicine

Amneal Pharmaceuticals (NASDAQ:AMRX) shareholders are still up 235% over 1 year despite pulling back 8.0% in the past week

Simply Wall St.

a year ago

Amneal Pharmaceuticals (NASDAQ:AMRX) shareholders are still up 235% over 1 year despite pulling back 8.0% in the past week

Amneal to Report First Quarter 2024 Results on May 3, 2024

Business Wire

a year ago

Amneal to Report First Quarter 2024 Results on May 3, 2024

Amneal to Ring the Nasdaq Closing Bell on April 2, 2024

Business Wire

a year ago

Amneal to Ring the Nasdaq Closing Bell on April 2, 2024

Amneal Receives U.S. FDA Approval for Ciprofloxacin and Dexamethasone Otic Suspension

Business Wire

a year ago

Amneal Receives U.S. FDA Approval for Ciprofloxacin and Dexamethasone Otic Suspension

Amneal Pharmaceuticals Inc (AMRX) Reports Mixed 2023 Financial Results

GuruFocus.com

a year ago

Amneal Pharmaceuticals Inc (AMRX) Reports Mixed 2023 Financial Results

Amneal Reports Fourth Quarter and Full Year 2023 Financial Results

Business Wire

a year ago

Amneal Reports Fourth Quarter and Full Year 2023 Financial Results

Amneal Enters into Exclusive European Licensing Agreement with Zambon Biotech for IPX203

Business Wire

a year ago

Amneal Enters into Exclusive European Licensing Agreement with Zambon Biotech for IPX203

Insiders the biggest winners as Amneal Pharmaceuticals, Inc.'s (NASDAQ:AMRX) market cap rises to US$1.8b

Simply Wall St.

a year ago

Insiders the biggest winners as Amneal Pharmaceuticals, Inc.'s (NASDAQ:AMRX) market cap rises to US$1.8b

Amneal to Participate at Upcoming Investor Conference

Business Wire

a year ago

Amneal to Participate at Upcoming Investor Conference

Amneal Announces Complete Response Resubmission for IPX203 New Drug Application

GlobeNewswire

a year ago

Amneal Announces Complete Response Resubmission for IPX203 New Drug Application

Compared to Estimates, Cimpress (CMPR) Q2 Earnings: A Look at Key Metrics

Zacks

a year ago

Compared to Estimates, Cimpress (CMPR) Q2 Earnings: A Look at Key Metrics

Amneal to Report Fourth Quarter and Full Year 2023 Results on March 1, 2024

Business Wire

a year ago

Amneal to Report Fourth Quarter and Full Year 2023 Results on March 1, 2024

Kodiak Gas Services Announces Pricing of $750 Million Senior Unsecured Notes Offering

PR Newswire

a year ago

Kodiak Gas Services Announces Pricing of $750 Million Senior Unsecured Notes Offering

CMS Awards ICF $33 Million Digital Modernization Contract

PR Newswire

a year ago

CMS Awards ICF $33 Million Digital Modernization Contract

Portable-Building Companies Strike $3 Billion Deal

The Wall Street Journal

a year ago

Portable-Building Companies Strike $3 Billion Deal

Kodiak Gas Services Announces Launch of $750 Million Senior Unsecured Notes Offering

PR Newswire

a year ago

Kodiak Gas Services Announces Launch of $750 Million Senior Unsecured Notes Offering

Kodiak Gas Services Announces Quarterly Dividend of $0.38 per Share of Common Stock

PR Newswire

a year ago

Kodiak Gas Services Announces Quarterly Dividend of $0.38 per Share of Common Stock

What's in Store for Rockwell Automation (ROK) in Q1 Earnings?

Zacks

a year ago

What's in Store for Rockwell Automation (ROK) in Q1 Earnings?

These 2 Transportation Stocks Could Beat Earnings: Why They Should Be on Your Radar

Zacks

a year ago

These 2 Transportation Stocks Could Beat Earnings: Why They Should Be on Your Radar

Knight Therapeutics Enters into Exclusive License Agreement with Amneal Pharmaceuticals for IPX203

GlobeNewswire

a year ago

Knight Therapeutics Enters into Exclusive License Agreement with Amneal Pharmaceuticals for IPX203

First Merchants Bank Announces Plans to Expand in Detroit, Bringing Financial Services to Fitzgerald

GlobeNewswire

a year ago

First Merchants Bank Announces Plans to Expand in Detroit, Bringing Financial Services to Fitzgerald

Is EverCommerce Inc. (NASDAQ:EVCM) Trading At A 21% Discount?

Simply Wall St.

a year ago

Is EverCommerce Inc. (NASDAQ:EVCM) Trading At A 21% Discount?

Business Wire

a year ago

MGE Energy Declares Regular Dividend

BancFirst (BANF) Q4 Earnings and Revenues Top Estimates

Zacks

a year ago

BancFirst (BANF) Q4 Earnings and Revenues Top Estimates

UK Sovereign Satellite Navigation Overlay Successfully Demonstrated for First Time

PR Newswire

a year ago

UK Sovereign Satellite Navigation Overlay Successfully Demonstrated for First Time

How did the spot bitcoin ETFs perform on their first trading day?

Yahoo Finance Video

a year ago

How did the spot bitcoin ETFs perform on their first trading day?

Is Now The Time To Put MGE Energy (NASDAQ:MGEE) On Your Watchlist?

Simply Wall St.

a year ago

Is Now The Time To Put MGE Energy (NASDAQ:MGEE) On Your Watchlist?

SITE Centers Provides 2023 and YTD 2024 Transactions Update

Business Wire

a year ago

SITE Centers Provides 2023 and YTD 2024 Transactions Update

Q3 Earnings Highlights: Braze (NASDAQ:BRZE) Vs The Rest Of The Sales And Marketing Software Stocks

StockStory

a year ago

Q3 Earnings Highlights: Braze (NASDAQ:BRZE) Vs The Rest Of The Sales And Marketing Software Stocks

Werner Enterprises taps new president from within

FreightWaves

a year ago

Werner Enterprises taps new president from within

Werner Enterprises Names Nathan Meisgeier as President

Business Wire

a year ago

Werner Enterprises Names Nathan Meisgeier as President

Amneal Launches Complex Generic Fluorometholone Ophthalmic Suspension

Business Wire

a year ago

Amneal Launches Complex Generic Fluorometholone Ophthalmic Suspension

EVP & CFO Deanna Lund Sells 6,000 Shares of Kratos Defense & Security Solutions Inc

GuruFocus.com

a year ago

EVP & CFO Deanna Lund Sells 6,000 Shares of Kratos Defense & Security Solutions Inc

Amneal Launched Record Number of 39 New Retail and Injectable Products in 2023, Including 13 in Q4 2023

Business Wire

a year ago

Amneal Launched Record Number of 39 New Retail and Injectable Products in 2023, Including 13 in Q4 2023

Enovis (ENOV) to Strengthen Portfolio Via Its Latest Buyout

Zacks

a year ago

Enovis (ENOV) to Strengthen Portfolio Via Its Latest Buyout

Kratos and Rancher Government Solutions Announce Strategic Partnership to Enable Customers to Seamlessly Deploy and Scale Virtual Ground Systems Using Kratos’ OpenSpace® Software Platform

GlobeNewswire

a year ago

Kratos and Rancher Government Solutions Announce Strategic Partnership to Enable Customers to Seamlessly Deploy and Scale Virtual Ground Systems Using Kratos’ OpenSpace® Software Platform

Semrush Holdings, Inc. to Present at Needham Growth Conference

Business Wire

a year ago

Semrush Holdings, Inc. to Present at Needham Growth Conference

Evergrande Auto’s Investment Agreement With Dubai Automaker Lapses

The Wall Street Journal

a year ago

Evergrande Auto’s Investment Agreement With Dubai Automaker Lapses

3 Top Tech Stocks Under $20 Per Share

Motley Fool

a year ago

3 Top Tech Stocks Under $20 Per Share

Those who invested in Indivior (LON:INDV) three years ago are up 118%

Simply Wall St.

a year ago

Those who invested in Indivior (LON:INDV) three years ago are up 118%

Neurocrine (NBIX) Soars 6.0%: Is Further Upside Left in the Stock?

Zacks

a year ago

Neurocrine (NBIX) Soars 6.0%: Is Further Upside Left in the Stock?

Global Conflicts Stir Sleeping Energy Giant in South America

The Wall Street Journal

a year ago

Global Conflicts Stir Sleeping Energy Giant in South America

Amneal to Participate at the 42nd Annual J.P. Morgan Healthcare Conference

Business Wire

a year ago

Amneal to Participate at the 42nd Annual J.P. Morgan Healthcare Conference

NWTN Collaborates with Abu Dhabi Islamic Bank for Innovative Auto Financing Solutions

PR Newswire

a year ago

NWTN Collaborates with Abu Dhabi Islamic Bank for Innovative Auto Financing Solutions

Kodiak Gas Services, Inc. to Acquire CSI Compressco LP in an $854 Million All-Equity Transaction

PR Newswire

a year ago

Kodiak Gas Services, Inc. to Acquire CSI Compressco LP in an $854 Million All-Equity Transaction

Amneal Announces Move to Nasdaq

Business Wire

a year ago

Amneal Announces Move to Nasdaq

3 Stocks to Watch From the Challenging Computer-Services Industry

Zacks

a year ago

3 Stocks to Watch From the Challenging Computer-Services Industry

Share on Social Networks: